CfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma.

ABSTRACT:

SUBMITTER: He Q 

PROVIDER: S-EPMC7354132 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature